Skip to main content

#161700

Anti-CD11a monoclonal antibody [GRS3]

Cat. #161700

Anti-CD11a monoclonal antibody [GRS3]

Cat. #: 161700

Sub-type: Primary antibody

Availability: 3-4 weeks

Target: CD11a

Class: Monoclonal

Application: FACS; IHC; ELISA; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot, Federico Garrido Torres-Puchol, Susana Pedrinaci Rodriguez

Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service

Primary Citation: Pedrinaci et al. 1989. Hybridoma. 8(1):13-23. PMID: 2564369

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD11a monoclonal antibody [GRS3]
  • Research fields: Cell biology;Cell signaling and signal transduction;Immunophenotyping;Stem cell biology
  • Clone: GRS3
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 95 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS; IHC; ELISA; WB
  • Description: CD11a antigen (Alpha chain of the LFA-1 antigen) functions in the immune system. It is involved in cellular adhesion and costimulatory signaling.
  • Immunogen: U937 cell line
  • Isotype: IgG1k
  • Recommended controls: Leukocytes

Target Details

  • Target: CD11a
  • Molecular weight: 95 kDa

Applications

  • Application: FACS; IHC; ELISA; WB

Handling

  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Pedrinaci et al. 1989. Hybridoma. 8(1):13-23. PMID: 2564369

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.